| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5840327 | ALZA | Transdermal drug delivery device having enhanced adhesion |
Aug, 2016
(7 years ago) | |
Testoderm is owned by Alza.
Testoderm contains Testosterone.
Testoderm has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Testoderm are:
- US5840327
Testoderm was authorised for market use on 12 October, 1993.
Testoderm is available in film, extended release;transdermal dosage forms.
The generics of Testoderm are possible to be released after 15 August, 2016.
Drugs and Companies using TESTOSTERONE ingredient
Market Authorisation Date: 12 October, 1993
Treatment: NA
Dosage: FILM, EXTENDED RELEASE;TRANSDERMAL
More Information on Dosage
TESTODERM family patents
